Ignite Creation Date:
2025-12-24 @ 4:24 PM
Ignite Modification Date:
2025-12-25 @ 2:18 PM
Study NCT ID:
NCT00298766
Status:
COMPLETED
Last Update Posted:
2012-06-25
First Post:
2006-03-01
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Open-Label Phase 1/2 Study of VELCADE for Injection in Patients With Light-chain (AL)-Amyloidosis
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-06
Start Date Type:
None
Primary Completion Date:
2009-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-09
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-01
First Submit QC Date:
None
Study First Post Date:
2006-03-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-07-16
Results First Submit QC Date:
None
Results First Post Date:
2010-08-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-06-19
Last Update Post Date:
2012-06-25
Last Update Post Date Type:
ESTIMATED